Kejal Pharmaceuticals Llp - Company Profile

It is a home appliances limited liability partnership based in Navi Mumbai, Maharashtra, India, established in 2019.
2019 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Kejal Pharmaceuticals Llp

Kejal Pharmaceuticals Llp, a active limited liability partnership, was established on 17 June 2019 in Navi Mumbai, Maharashtra, India. Engaging in retailers within the home appliances sector, it holds LLPIN: AAP-6494. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.50 M.

Its leadership includes Rajesh Lalitkumar Shah (Designated Partner), Bhavana Kiran Kothari (Designated Partner). Past directors included Meet Rajesh Shah, Raksha Rajesh Shah. Its latest date of accounts and solvency statement 31 March 2025. It is based at Flat 33/A, Pl 63, Sector 17, Kaveri, Vashi,, Navi Mumbai, Maharashtra, 400703.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAP-6494

  • Incorporation Date

    17 June 2019

  • Total Obligation of Contribution

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.50 M
  • Company Age 6 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Kejal Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kejal Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kejal Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Rajesh Lalitkumar Shah Designated Partner 17 Jun 2019 Current
Bhavana Kiran Kothari Designated Partner 18 Dec 2025 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 18 Dec 2025 Past
Pramod Abcsdd Designated Partner 29 Aug 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kejal Pharmaceuticals Llp.

Enhance accessibility to Kejal Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kejal Pharmaceuticals Llp revenue growth over time
Kejal Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kejal Pharmaceuticals Llp?

Unlock access to Kejal Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kejal Pharmaceuticals Llp?

Unlock and access historical data on people associated with Kejal Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kejal Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kejal Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kejal Pharmaceuticals Llp
Recent Activity within the Organization
  • Director Appointment

    Bhavana Kiran Kothari was appointed as a Designated Partner was appointed as a Designated Partner on 18 Dec 2025 & has been associated with this company since 1 month 20 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Kejal Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Kejal Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Rajesh Lalitkumar Shah was appointed as a Designated Partner was appointed as a Designated Partner on 17 Jun 2019 & has been associated with this company since 6 years 7 months . was completed.

  • LLP Incorporation

    Progress on Kejal Pharmaceuticals Llp was registered on 17 Jun 2019 with Roc Mumbai & aged 6 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Kejal Pharmaceuticals Llp?

The LLPIN of Kejal Pharmaceuticals Llp is AAP-6494.

Where is Kejal Pharmaceuticals Llp headquartered?

Kejal Pharmaceuticals Llp is headquartered at Flat 33/A, Pl 63, Sector 17, Kaveri, Vashi,, Navi Mumbai, Maharashtra, 400703.

When was Kejal Pharmaceuticals Llp incorporated?

Kejal Pharmaceuticals Llp was incorporated on 17 June 2019.

Who are the current directors of Kejal Pharmaceuticals Llp?

The current directors of Kejal Pharmaceuticals Llp are

What is the primary industry of Kejal Pharmaceuticals Llp?

The primary industry of Kejal Pharmaceuticals Llp is Home Appliances.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available